Trial Profile
Transmolecular Imaging of Recurrent Prostate Carcinoma With Exploration of Genomic Markers Differences Between Local and Distant Recurrence
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fluciclovine 18F (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 12 Dec 2018 Status changed from active, no longer recruiting to completed.
- 15 Nov 2018 Planned End Date changed from 1 Oct 2018 to 1 Nov 2019.
- 15 Nov 2018 Planned primary completion date changed from 1 Oct 2018 to 1 Nov 2019.